Работы, цитирующие эту работу

Работ: 2

Работа: Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer

1. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

   Shunshun Bao, Mohammad Darvishi, Ali H. Amin +12

   Обзорная статьяChemokine receptors and signalingJournal of Cancer Research and Clinical Oncology2023Цитирований: 1

   ABIABI:AkademIndex/openalex/2023.review-article.000025

2. Breaking Barriers: Nucleic Acid Aptamers in Gastrointestinal (GI) Cancers Therapy

   Herlina Uinarni, Enwa Felix Oghenemaro, Soumya V. Menon +7

   Обзорная статьяAdvanced biosensing and bioanalysis techniquesCell Biochemistry and Biophysics2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.review-article.000081